Pediatric blood & cancer
-
Pediatric blood & cancer · Feb 2013
Aspergillus galactomannan antigen assay and invasive aspergillosis in pediatric cancer patients and hematopoietic stem cell transplant recipients.
Invasive aspergillosis (IA) is a major cause of morbidity and mortality in immunocompromised children. We investigated the usefulness of an Aspergillus galactomannan (GM) antigen assay as a diagnostic tool for IA in pediatric cancer patients and hematopoietic cell transplantation (HCT) recipients. ⋯ Having a positive GM assay at least twice is useful in diagnosing IA in pediatric patients with cancer and HCT recipients.